Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Preference for Lantus SoloSTAR vs Vial/Syringe in T2DM
NCT01226043Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Oct 2010; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01226043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226043.